Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Shake Shack Stock Gets Shaken After Earnings Miss

Shake Shack stock plunged after weak earnings, but Wall Street still sees upside as the company pushes ahead with expansion plans.

MarketBeat

On Holdings Sets Up for Marathon Rally: New Highs Are Coming

On Holdings is taking share in core markets, with strength tied to its growth pillars, and raising profit guidance as leverage improves.

MarketBeat

Clearfield Sees Fiber Demand Stabilizing as Bookings Rise, Data Center Prospects Build

Clearfield (NASDAQ:CLFD) executives said demand across the company’s fiber connectivity markets is stabilizing after a period of inventory corrections, funding uncertainty and uneven broadband deployment activity, with management pointing to stronger bookings, community broadband momentum and emergi

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Novanta Q1 Earnings Call Highlights

Novanta (NASDAQ:NOVT) reported stronger-than-expected first-quarter 2026 results, with management citing broad-based bookings growth, accelerating demand in automation and medical markets, and rising exposure to artificial intelligence-related infrastructure applications. Chair and Chief Executive

MarketBeat

SOLV Energy Q1 Earnings Call Highlights

SOLV Energy (NASDAQ:MWH) reported sharply higher first-quarter revenue and adjusted earnings, raised its full-year profit outlook and said demand for solar, storage and grid infrastructure remains strong as U.S. power needs accelerate. On the company’s first-quarter 2026 earnings call, Chief Execut

MarketBeat

Gladstone Land Q1 Earnings Call Highlights

Gladstone Land (NASDAQ:LAND) reported a first-quarter net loss as management said it continues to work through tenant issues, vacant farms and a greater reliance on crop-participation arrangements, while early pistachio revenue helped lift adjusted funds from operations from a year earlier. Chairma

MarketBeat

Kopin Q1 Earnings Call Highlights

Kopin (NASDAQ:KOPN) reiterated its full-year 2026 revenue outlook and highlighted a series of defense and AI infrastructure initiatives on its first-quarter earnings call, with Chief Executive Michael Murray describing the period as “one of the most exciting stretches” in the company’s history. The

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Harrow Q1 Earnings Call Highlights

Harrow (NASDAQ:HROW) executives said the company’s first-quarter results were weighed down by a discrete revenue issue tied to VEVYE coverage and high-deductible patients, but management repeatedly emphasized that underlying demand for its core ophthalmic products is accelerating. On the company’s

MarketBeat

JD.com Q1 Earnings Call Highlights

JD.com (NASDAQ:JD) reported a faster pace of revenue growth and higher profitability in the first quarter of 2026, as gains in general merchandise, marketplace services and logistics helped offset continued pressure in electronics and home appliances. Chief Executive Officer Sandy Xu said total rev

MarketBeat

The DRAM Shake-Up: Samsung Stumbles, Micron Chases $1000

Ongoing labor disruptions at competitor Samsung Electronics could create a significant pricing power advantage for U.S.-based memory maker Micron Technology.

MarketBeat

Figure Technology Solutions Q1 Earnings Call Highlights

Figure Technology Solutions (NASDAQ:FIGR) reported sharply higher first-quarter 2026 revenue and profitability as executives emphasized that the company is positioning itself as a blockchain-native capital markets platform rather than a traditional home equity lender. Chief Executive Officer Michae

MarketBeat

eToro Group Q1 Earnings Call Highlights

eToro Group (NASDAQ:ETOR) reported a strong start to 2026, with executives pointing to record public-company net contribution and adjusted EBITDA, accelerating funded account growth and a shift in trading activity from crypto toward commodities and other capital markets products. On the company’s f

MarketBeat

Camtek Q1 Earnings Call Highlights

Camtek (NASDAQ:CAMT) reported first-quarter revenue of $121.7 million, slightly ahead of its guidance, as management pointed to strong demand tied to artificial intelligence, high-bandwidth memory and advanced packaging applications. Chief Executive Officer Rafi Amit said approximately 50% of quart

MarketBeat

Arvinas Q1 Earnings Call Highlights

Arvinas (NASDAQ:ARVN) said its first quarter was marked by the FDA approval of VEPPANU, a new licensing agreement with Rigel Pharmaceuticals and continued progress across a clinical-stage pipeline focused on targeted protein degradation. President and Chief Executive Officer Randy Teel said the app

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Alico Q2 Earnings Call Highlights

Alico (NASDAQ:ALCO) reported second-quarter fiscal 2026 net income of $11.4 million, or $1.49 per diluted share, as the Florida land and agribusiness company continued to shift away from citrus production and toward land monetization, leasing and development initiatives. President and Chief Executi

MarketBeat

Achieve Life Sciences Q1 Earnings Call Highlights

Achieve Life Sciences (NASDAQ:ACHV) used its first-quarter 2026 earnings call to outline a transition period marked by new leadership, a major financing, manufacturing changes tied to its cytisinicline regulatory timeline and preparations for a potential commercial launch in 2027. Dr. Andrew Goldbe

MarketBeat

Dürr Aktiengesellschaft Q1 Earnings Call Highlights

Dürr Aktiengesellschaft (ETR:DUE) said its first-quarter 2026 results largely matched internal expectations, with management pointing to resilient performance in its automotive and woodworking divisions despite continued geopolitical and economic uncertainty. CEO Jochen Weyrauch said the war in the

MarketBeat

MP Materials Is Quietly Building a Rare Earth Powerhouse

MP Materials is back with its latest earnings update, characterized by multiple beats and progress on its key rare-earth operations.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

AI Demand Fuels Strong Q1 Earnings for Constellation Energy

Constellation Energy stock rises on strong Q1 earnings as AI data center demand and nuclear power growth support the long-term CEG bull case

MarketBeat

Celsius Says Energy Drink Demand Still Strong as Shelf Reset Weighs on Growth

Celsius (NASDAQ:CELH) executives said the energy drink category remains stronger than expected, while the company is working through a temporary timing gap tied to SKU rationalization and shelf-space changes for its core CELSIUS brand. Speaking at a Staples Forum, Chief Financial Officer Jarrod Lan

MarketBeat

Pangaea Logistics Solutions Q1 Earnings Call Highlights

Pangaea Logistics Solutions (NASDAQ:PANL) reported a stronger start to 2026, with management pointing to higher shipping activity, firmer dry bulk market conditions and continued benefits from its integrated logistics model during the company’s first-quarter earnings call. Chief Executive Officer M

MarketBeat

Legend Biotech Q1 Earnings Call Highlights

Legend Biotech (NASDAQ:LEGN) reported sharply higher first-quarter 2026 sales for CARVYKTI, its CAR T therapy for multiple myeloma, as management said demand continued to move into earlier lines of treatment and international markets expanded. Chief Executive Officer Ying Huang said the company beg

MarketBeat

Allot Q1 Earnings Call Highlights

Allot (NASDAQ:ALLT) reported a stronger start to 2026, with management pointing to accelerating revenue growth, expanding cybersecurity revenue and record operating cash flow during the company’s first-quarter earnings call. Chief Executive Officer Eyal Harari said first-quarter revenue rose 14% ye

MarketBeat

Organigram Global Q2 Earnings Call Highlights

Organigram Global (NASDAQ:OGI) reported a weaker second quarter for fiscal 2026, with management attributing the decline to operational issues in key product categories, softer Canadian cannabis market growth and continued challenges with international flower specifications. Chief Executive Officer

MarketBeat

Acumen Pharmaceuticals Q1 Earnings Call Highlights

Acumen Pharmaceuticals (NASDAQ:ABOS) said its Phase 2 ALTITUDE-AD trial of sabirnetug remains on track, with top-line results expected late in 2026, as the company continues to advance its broader Alzheimer’s disease pipeline. On the company’s first-quarter 2026 earnings call, Chief Executive Offic

1 … 62 63 64 65

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.